15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | 22,8 | |||||
RBC () | 1,5 | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | |||||
HGB () | 130-170\ | 120-160\ | () | |||||
HCT () | 40-48% | 36-42% | 0,6 | 1-6 % | 0,04-0,9*109\ | |||
() | 17,4 | 45-70% | 1,8-7,7*109\ | |||||
. | 0,85- 1,05 | 0,8-1,05 | 0-5 % | 0-0,2*109 \ | ||||
MCV(. ) | 80-94 | 81-99 | 0-1 % | 0,0-0,2*109 \ | ||||
MCHC( Hb ) | 30-38 \ | 0-36\ | 7,2 | 19-34 % | 1,0-4,5*109 \ | |||
4,8 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,2-1,2 | 10-70*109 \ | |||||||
7,2 |
60 N N
15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | ||||||
RBC () | 3,2 | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | |||||
HGB () | 130-170\ | 120-160\ | () | |||||
HCT () | 40-48% | 36-42% | 0,26 | 1-6 % | 0,04-0,9*109\ | |||
() | 7,8 | 45-70% | 1,8-7,7*109\ | |||||
. | 0,9 | 0,85- 1,05 | 0,8-1,05 | 0-5 % | 0-0,2*109 \ | |||
MCV(. ) | 80-94 | 81-99 | 0-1 % | 0,0-0,2*109 \ | ||||
MCHC( Hb ) | 30-38 \ | 0-36\ | 1,04 | 19-34 % | 1,0-4,5*109 \ | |||
0,52 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,2-1,2 | 10-70*109 \ | |||||||
16,38 |
N N
|
|
15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | ||||||
RBC () | 2,7 | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | |||||
HGB () | 130-170\ | 120-160\ | () | |||||
HCT () | 40-48% | 36-42% | 0,04 | 1-6 % | 0,04-0,9*109\ | |||
() | 2,36 | 45-70% | 1,8-7,7*109\ | |||||
. | 0,85- 1,05 | 0,8-1,05 | 0,04 | 0-5 % | 0-0,2*109 \ | |||
MCV(. ) | 80-94 | 81-99 | 0-1 % | 0,0-0,2*109 \ | ||||
MCHC( Hb ) | 30-38 \ | 0-36\ | 0,88 | 19-34 % | 1,0-4,5*109 \ | |||
0,28 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,1 | 0,2-1,2 | 10-70*109 \ | ||||||
22 N N
15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | 0,3 | |||||
RBC () | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | 0,9 | |||||
HGB () | 130-170\ | 120-160\ | () | 2,4 | ||||
HCT () | 40-48% | 36-42% | 6,4 | 1-6 % | 0,04-0,9*109\ | |||
() | 15,0 | 45-70% | 1,8-7,7*109\ | |||||
. | 0,9 | 0,85- 1,05 | 0,8-1,05 | 1,2 | 0-5 % | 0-0,2*109 \ | ||
MCV(. ) | 80-94 | 81-99 | 0,6 | 0-1 % | 0,0-0,2*109 \ | |||
MCHC( Hb ) | 30-38 \ | 0-36\ | 3,0 | 19-34 % | 1,0-4,5*109 \ | |||
1,2 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,2-1,2 | 10-70*109 \ | |||||||
24 N N
15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | ||||||
RBC () | 2,4 | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | |||||
HGB () | 130-170\ | 120-160\ | () | |||||
HCT () | 40-48% | 36-42% | 0,02 | 1-6 % | 0,04-0,9*109\ | |||
() | 0,78 | 45-70% | 1,8-7,7*109\ | |||||
. | 0,85- 1,05 | 0,8-1,05 | 0-5 % | 0-0,2*109 \ | ||||
MCV(. ) | 80-94 | 81-99 | 0-1 % | 0,0-0,2*109 \ | ||||
MCHC( Hb ) | 30-38 \ | 0-36\ | 1,06 | 19-34 % | 1,0-4,5*109 \ | |||
0,14 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,2-1,2 | 10-70*109 \ | |||||||
48 N N
|
|
15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | ||||||
RBC () | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | ||||||
HGB () | 130-170\ | 120-160\ | () | |||||
HCT () | 40-48% | 36-42% | 0,03 | 1-6 % | 0,04-0,9*109\ | |||
() | 1,17 | 45-70% | 1,8-7,7*109\ | |||||
. | 1,2 | 0,85- 1,05 | 0,8-1,05 | 0-5 % | 0-0,2*109 \ | |||
MCV(. ) | 80-94 | 81-99 | 0-1 % | 0,0-0,2*109 \ | ||||
MCHC( Hb ) | 30-38 \ | 0-36\ | 1,35 | 19-34 % | 1,0-4,5*109 \ | |||
0,45 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,01 | 0,2-1,2 | 10-70*109 \ | ||||||
24 N N
15 20
\
36
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | 1,0 | |||||
RBC () | 1,2 | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | 2,5 | ||||
HGB () | 130-170\ | 120-160\ | () | 4,0 | ||||
HCT () | 40-48% | 36-42% | 5,0 | 1-6 % | 0,04-0,9*109\ | |||
() | 45-70% | 1,8-7,7*109\ | ||||||
. | 0,85- 1,05 | 0,8-1,05 | 1,5 | 0-5 % | 0-0,2*109 \ | |||
MCV(. ) | 80-94 | 81-99 | 1,0 | 0-1 % | 0,0-0,2*109 \ | |||
MCHC( Hb ) | 30-38 \ | 0-36\ | 5,0 | 19-34 % | 1,0-4,5*109 \ | |||
2,5 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,2-1,2 | 10-70*109 \ | |||||||
2,5 |
56 N N
|
|
15 20
\
N | N | % | N (%) | N (. ) | ||||
WBC () | 4,5-9,0* 109 \ | 4,8-9,0* 109 \ | ||||||
RBC () | 4,5 | 4,3-5,7* 1012\ | 3,8-5,3* 1012\ | |||||
HGB () | 130-170\ | 120-160\ | () | 0,24 | ||||
HCT () | 40-48% | 36-42% | 2,16 | 1-6 % | 0,04-0,9*109\ | |||
() | 7,2 | 45-70% | 1,8-7,7*109\ | |||||
. | 0,8 | 0,85- 1,05 | 0,8-1,05 | 0-5 % | 0-0,2*109 \ | |||
MCV(. ) | 80-94 | 81-99 | 0-1 % | 0,0-0,2*109 \ | ||||
MCHC( Hb ) | 30-38 \ | 0-36\ | 1,68 | 19-34 % | 1,0-4,5*109 \ | |||
0,72 | 1,8-11% | 0,1-0,6*109 \ | ||||||
PLT () | 180-380* 109\ | 180-380* 109\ | . | |||||
0,2-1,2 | 10-70*109 \ | |||||||
36 N N
15 20
\